Sen. Schumer latest to endorse MTM legislation
WASHINGTON — Sen. Charles Schumer, D-N.Y., on Monday became the 11th senator to sign on as a co-sponsor for the Medication Therapy Management Empowerment Act of 2011. The legislation was first introduced in February by Sen. Kay Hagan, D-N.C.
S. 274 seeks to enhance a pharmacy’s ability to partner with patients around counseling and medication therapy management services with the goal of increasing medication adherence. "Failure to take medications as prescribed costs over $290 billion annually. The problem of nonadherence is particularly important for patients with chronic diseases that require use of medications," the bill reads.
The bill would enable any pharmacy participating in the network of a Medicare Part D prescription drug plan to offer medication therapy management services and be reimbursed for those services based on "the resources used and the time required to provide such services."
"This bill will allow more seniors to bring all of their medications to the pharmacy and ensure they are following their medication regimens," Hagan stated in introducing the bill earlier this year. "If more seniors are educated to properly follow their doctor’s orders, we can save lives and Medicare dollars. In North Carolina, these programs have saved millions of dollars, and our seniors have avoided countless healthcare complications."
The legislation was referred to the Senate Committee on Finance in February.
Nycomed US announces executive changes
MELVILLE, N.Y. — In line with its new position as a stand-alone corporation, the former U.S. subsidiary of a Swiss drug maker has appointed a new leader.
Nycomed US announced that Brian Markison, former chairman and CEO of King Pharmaceuticals, will lead the company as president, CEO and a member of the board. The company also appointed Jeff Bailey as COO and John Golubieski as CFO. Both Bailey and Golubieski also held executive roles at King.
Nycomed US was the U.S. subsidiary of Nycomed, prior to the pharmaceutical company’s acquisition by Takeda. Nycomed US will continue to be owned by Nycomed’s current private equity owners, but will operate as an independent entity.
"I am delighted, along with Jeff and John, to join the team at Nycomed US. This is an exciting time for the company because we have the opportunity to grow aggressively and forge our future as an independent entity," Markison said. "Jeff and John are great additions to an already strong and focused management team and I am confident we can leverage the company’s financial strength and unique platform within the dermatology market to drive further growth in our business."
Omnicare appoints SVP, general manager for RxCrossroads
COVINGTON, Ky. — The VP distribution operations for Omnicare’s RxCrossroads business has stepped into a new role, Omnicare announced Tuesday.
Dan Thomas was appointed to the role of SVP and general manager for RxCrossroads, an Omnicare division that provides specialized solutions specifically tailored to the biotechnology and pharmaceutical industries. Thomas, who has worked in the unit for 27 years, will have full operational responsibility in his new role and report to Nitin Sahney, EVP and president of Omnicare’s Specialty Care Group.
"Dan is a solid operator who has an extensive understanding for our manufacturing clients’ needs," Sahney said. “Over the years, he has been an important contributor to the evolution of RxCrossroads. With this appointment, his value becomes even more significant as we embark upon our next era of growth."
In related news, Omnicare also has named a new EVP human resources. Priscilla Stewart-Jones will join the company next month, reporting to Omnicare’s CEO, John Figueroa.